Identification
Personal identification
- Full name
- Sérgia Velho
- Gender
- Female
Citation names
- VELHO, SERGIA
Author identifiers
- Ciência ID
- B316-B47C-2855
- ORCID iD
- 0000-0002-7104-8234
- Google Scholar ID
- qmAvPh0AAAAJ&hl
- Scopus Author Id
- 8738558400
Email addresses
- svelho@ipatimup.pt (Professional)
Telephones
- Telephone
-
- 226074900 (Professional)
Addresses
- Rua Alfredo Allen, 208, 4200-135, Porto, Porto, Portugal (Professional)
Websites
- https://www.i3s.up.pt/content/people?id=166&idg=17 (Professional)
Knowledge fields
- Medical and Health Sciences - Clinical Medicine - Oncology
Languages
Language | Speaking | Reading | Writing | Listening | Peer-review |
---|---|---|---|---|---|
English | Advanced (C1) | Advanced (C1) | Advanced (C1) | Advanced (C1) | |
German | Beginner (A1) | Beginner (A1) | Beginner (A1) | Beginner (A1) | |
Spanish; Castilian | Beginner (A1) | Intermediate (B1) | Beginner (A1) | Beginner (A1) |
Education
Degree | Classification | |
---|---|---|
2006 - 2010
Concluded
|
Human Biology (Doutoramento)
Universidade do Porto Faculdade de Medicina, Portugal
"The role of BRAF and KRAS activating mutations in deficient and proficient MMR colorectal carcinomas." (THESIS/DISSERTATION)
|
Approved |
1999 - 2003
Concluded
|
Biology (Licenciatura)
Universidade do Porto Faculdade de Ciências, Portugal
"Screening of germline mutations in members of the ERM family in HDGC." (THESIS/DISSERTATION)
|
15 |
Affiliation
Science
Category Host institution |
Employer | |
---|---|---|
2022 - Current | Auxiliary Researcher (Research) | Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal |
2014 - 2019 | Auxiliary Researcher (Research) | Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal |
2011 - 2013 | Postdoc (Research) | Harvard Medical School, United States |
Teaching in Higher Education
Category Host institution |
Employer | |
---|---|---|
2017 - 2019 | Invited Adjunct Teacher (Polytechnic Teacher) | Instituto Politécnico do Porto Escola Superior de Saúde, Portugal |
2017 - 2018 | Invited Assistant (Polytechnic Teacher) | Instituto Politécnico do Porto, Portugal |
Positions / Appointments
Category Host institution |
Employer | |
---|---|---|
2023 - 2025 | Honorary Collaborator | Universidad de Valladolid, Spain |
2019 - 2021 | Junior Researcher | Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal |
2006 - 2010 | PhD student | Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal |
Projects
Contract
Designation | Funders | |
---|---|---|
2023/02/01 - 2024/07/31 | Novos biomarcadores fecais para deteção precoce de lesões pré-malignas e cancro: Otimização do modelo atual de rastreio em
cancro colorretal
2022.09051.PTDC
Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal
Instituto de Astrofísica e Ciências do Espaço, Portugal |
Fundação para a Ciência e a Tecnologia
Ongoing
|
2023/01/01 - 2024/06/30 | Deconstructing the Cell Communication Routes of mutant KRAS Colorectal Liver to Lung Metastasis: improving patient survival
2022.05346.PTDC
Research team member
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
Instituto Português de Oncologia de Coimbra Francisco Gentil EPE, Portugal |
Fundação para a Ciência e a Tecnologia
Ongoing
|
2018/10/15 - 2021/10/14 | MAGICIAM: um sistema imunomodelador de macrófagos para prevenir a invasão e metastização das células tumorais
PTDC/BTM-SAL/31859/2017
Instituto Nacional de Engenharia Biomédica, Portugal
Universidade de Lisboa Instituto de Medicina Molecular João Lobo Antunes, Portugal Associação para a Investigação e Desenvolvimento da Faculdade de Medicina, Portugal Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal |
Fundação para a Ciência e a Tecnologia
Concluded
|
2017/01/01 - 2021/03/31 | Estaminalidade das células do cancro: um desafio e uma oportunidade para avançar no tratamento em Oncologia
SAICTPAC/0022/2015
Universidade de Coimbra Centro de Neurociências e Biologia Celular, Portugal
Instituto Nacional de Engenharia Biomédica, Portugal Fundação Calouste Gulbenkian, Portugal Universidade de Coimbra, Portugal Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal |
Fundação para a Ciência e a Tecnologia
Ongoing
|
2019 - 2021 | MAGICIAM: a MAcrophaGe Immunomodulatory-delivery system to prevent Cancer Invasion And Metastasis
POCI-01-0145-FEDER-031859
Researcher
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
|
Fundação para a Ciência e a Tecnologia
Ongoing
|
2018 - 2021 | Pre-clinical evaluation of novel chemical compounds for cancer treatment: tackling unmet clinical needs
POCI-01-0145-FEDER-031354
Principal investigator
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
|
Fundação para a Ciência e a Tecnologia
Ongoing
|
2018 - 2019 | Influence of an optimized combined dietary and exercise intervention on cytokine profile and NK cell infiltration of the tumor:
an exploratory pilot study
Researcher
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
|
Sociedade Portuguesa de Gastroenterologia
Concluded
|
2017 - 2019 | Tackling CANcer STEM CELls: a challenge and an opportunity to advance in anti¬cancer therapy
POCI-01-0145-FEDER-016390
Principal investigator
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
Instituto de Medicina Molecular, Portugal |
Fundação para a Ciência e a Tecnologia
Concluded
|
2016 - 2019 | Advancing cancer research: from basic knowledge to application
NORTE-01-0145-FEDER-000029
Principal investigator
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
|
N2020 program
Concluded
|
2017 - 2018 | OncoAdvanC+: Bringing new solutions for cancer therapy
Principal investigator
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
|
RESOLVE program
Concluded
|
2014 - 2018 | Epithelial stromal crosstalk as a major driver of colorectal cancer development and progression: an approach to identify its
master regulators
IF/00136/2013/CP1184/CT0003
Principal investigator
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
|
Fundação para a Ciência e a Tecnologia
Concluded
|
2015 - 2016 | Mesenchymal stem cells in inflamatory bowel disease: therapeutic strategy or cancer promoters?
Principal investigator
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
|
GEDII |
2013 - 2015 | Functional Significance of E-cadherin Germline Missense Mutations in Diffuse Gastric Cancer
POCTI/CBO/44849/2002
Researcher
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
|
Fundação para a Ciência e a Tecnologia
Concluded
|
2013 - 2015 | Molecular mechanisms underlying cancer cell invasion in two cancer disease models, gastric and breast
Researcher
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
|
Concluded
|
2011/01/01 - 2012/12/31 | Projecto Estratégico - LA 3 - 2011-2012
PEst-C/SAU/LA0003/2011
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
|
Fundação para a Ciência e a Tecnologia
Concluded
|
2008 - 2011 | MLK3, a new mutated gene in MSI colorectal cancer
PTDC/SAU-OBD/68310/2006
Researcher
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
|
Fundação para a Ciência e a Tecnologia
Concluded
|
2005 - 2008 | In mismatch repair deficiency colorectal cancer are BRAF and KRAS new prognostic and therapeutic tools?
POCI/SAU-OBS/56921/2004
Researcher
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
|
Fundação para a Ciência e a Tecnologia
Concluded
|
Outputs
Publications
Book chapter |
|
Conference poster |
|
Journal article |
|
Preprint |
|
Other
Other output |
|
Activities
Oral presentation
Presentation title | Event name Host (Event location) |
|
---|---|---|
2024 | Tumor-Hematopoietic Communication in Colorectal Cancer Immune Evasion | The Ecology of Cancer
Champalimaud Foundation
|
2023 | Translational research in Portugal: Current state and challenges from the researcher perspective | XI Perspectives in Oncology
XI Perspectives in Oncology (Portugal)
|
2022 | Mutant KRAS & the tumor microenvironment: It takes two to tango. | Seminar at CESPU
CESPU (Portugal)
|
2022 | Mutant KRAS elicits an intestinal-spleen immunoregulatory crosstalk during intestinal tumorigenesis | Symposium on Immunomodulation in Cancer and Regeneration
Symposium on Immunomodulation in Cancer and Regeneration
|
2019 | Molecular study advances: The impact on patients’ selection for CRT | Jornadas Portuguesas de Cirurgia – Colorectal cancer pathology: a multidisciplinar approach
Fundação Cupertino de Miranda (Porto, Portugal)
|
2018 | KRAS mediates colorectal cancer cell invasion induced by fibroblasts | International Conference on Tumor Microenvironment Progression, Therapy and Prevention
The International Cancer Microenvironment Society (Lisbon, Portugal)
|
2017 | ITGA6 as a molecular mediator of KRAS-, BRAF- and PIK3CA-induced colorectal cancer stem cell phenotype | Translating Colorectal Cancer Research workshop
Cost Action BM1 206 (Porto, Portugal)
|
2014 | How oncogenes and non-neoplastic components play together for colorectal cancer development | 4th i3S Annual Meeting
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal (Póvoa de Varzim, Portugal)
|
2014 | Medicina molecular: da investigação à prática clínica. A contribuição da investigação no tratamento do cancro colo-retal | III In4Med
Universidade de Coimbra (Coimbra, Portugal)
|
2013 | MAPK signaling activation in colorectal cancer | 7th National Meeting on Cell Signalling - SINAL 2013
Universidade de Aveiro (Aveiro, Portugal)
|
2013 | N-RAS mutations in colorectal cancer. Mechanisms of oncogenesis and therapeutic implications | Colrain meeting
(Colrain, United States)
|
2010 | Mapk oncogenic activation in MSI gastrointestinal tumours | 1st i3S Annual Meeting
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal (Póvoa de Varzim, Portugal)
|
Supervision
Thesis Title Role |
Degree Subject (Type) Institution / Organization |
|
---|---|---|
2021/01 - Current | Deciphering the role of cholesterol as a mediator of oncogenic signaling and immune regulation in colorectal cancer
Supervisor of Ana Luísa Machado
|
Biomedicine (PhD)
Universidade do Porto Faculdade de Medicina, Portugal
|
2019 - Current | Targeting HER2-positive gastric and esophageal cancers with functionalized lipid nanoparticles of docetaxel: development and
characterization of thermosensitive in situ gels for intratumoral drug delivery
Co-supervisor of Ana Camila Gomes Marques
|
Pharmaceutical Sciences (PhD)
Universidade do Porto Faculdade de Farmácia, Portugal
|
2023/09/01 - 2024/12/13 | Unveiling the role of cholesterol in the colorectal cancer microenvironment
Supervisor
|
Master degree in Molecular Medicine and Oncology (Master)
Universidade do Porto Faculdade de Medicina, Portugal
|
2020 - 2024 | The role of BRAF V600E mutation and inflammation in the development of colorectal cancer
Supervisor of Susana Mendonça
|
Biomedicine (PhD)
Universidade do Porto Faculdade de Medicina, Portugal
|
2020 - 2024 | Identification of therapeutic targets and disease biomarkers for mutant KRAS cancer patients: fulfilling an unmet clinical
need
Supervisor of Flávia Martins
|
Biomedicine (PhD)
Universidade do Porto Faculdade de Medicina, Portugal
|
2022/09/01 - 2023/07/31 | Understanding the role of extracellular vesicles derived from mutant KRAS
colorectal cancer cells on T-cell activation and exhaustion
Co-supervisor
|
Master Degree in Biomedical Research (Master) |
2022/09/01 - 2023/07/31 | Non-invasive monitoring of metastatic colorectal cancer in circulating tumor DNA and exosomal RNA
Supervisor
|
Master Degree in Oncology - Clinical Oncology (Master)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
|
2022/01/01 - 2023/07/31 | In silico dissection of mutant KRAS and cholesterol immunomodulatory effects
Co-supervisor
|
Master Degree in Biostatistics and Bioinformatics Applied to Health (Master) |
2022/02/01 - 2022/07/31 | Elucidating the mechanisms of colorectal cancer
Co-supervisor
|
Biomedical Engineering (Master) |
2021/09/01 - 2022/07/31 | The role of hypoxia on immunomodulation at the colon cancer microenvironment.
Co-supervisor
|
Oncology (Master) |
2021/09/01 - 2022/07/31 | Evaluation of the impact of 2D versus 3D cell culture systems in the communication and modulation of the tumour microenvironment
Supervisor
|
Oncobiology (Master) |
2018 - 2022 | Exploring the impact of mutant kras on epithelial-fibroblasts interactions during coloraractal initiation and progression
Supervisor of Patrícia Dias Carvalho
|
Patologia e Genética Molecular (PhD)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
|
2020/09 - 2021/07 | Deciphering the functional role of KRAS-induced SUSD2 downregulation in colorectal cancer
Supervisor of Diogo Coelho
|
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
|
2017 - 2021 | Centriole aberrations and cancer stem cells
Co-supervisor of Irina Suheila Martins Leal Fonseca
|
Graduate Programme Science for Development (PhD)
Universidade Nova de Lisboa, Portugal
|
2020 - 2020 | Identification of Biomarkers of Resistance to Immune Checkpoint Inhibitors
Supervisor of Tânia Rodrigues Vieira
|
Biochemistry (Degree)
Universidade do Porto Faculdade de Ciências, Portugal
|
2020 - 2020 | Pre-clinical evaluation of novel chemical compounds for cancer treatment: tackling unmet clinical needs
Supervisor of Ana Sofia Valdeira
|
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
|
2018 - 2019 | To identify the key molecular players in mediating colorectal cancer cell invasion and metastization induced by cancer-associated
fibroblasts
Supervisor of Flávia Martins
|
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
|
2017 - 2019 | Influence of KRAS activation in the colorectal cancer immunosurveillance
Supervisor of Ana Luísa Machado
|
Bioquímica em Saúde (Master)
Instituto Politécnico do Porto Escola Superior de Saúde, Portugal
|
2017 - 2019 | CSC niche: the role of cellular and non-cellular components from the tumour microenvironment
Supervisor of Susana Mendonça
|
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
|
2016 - 2018 | To identify the key molecular players in mediating colorectal cancer cell invasion and metastization induced by cancer-associated
fibroblasts
Supervisor of Patrícia Dias Carvalho
|
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
|
2017 - 2017 | Cancer-associated fibroblasts and tumor-associated macrophages: exploring their mutual regulation.
Supervisor of Carlos Ferreira Guimarães
|
Bioengenharia (Master)
Universidade do Porto Faculdade de Engenharia, Portugal
|
2015 - 2016 | Modulation of colorectal cancer stem cell pool and its crosstalk with tumor microenvironment by KRas, BRaf, and PIK3CA mutations
Supervisor of André Emanuel Serra Roma
|
Investigação Biomédica (Master)
Universidade de Coimbra, Portugal
|
2014 - 2014 | Characterization of the expression of intestinal homeostasis-related signaling pathways in KRAS mutant colorectal cancer cell
lines
Supervisor of Anjali Balgobind
|
Van Hall Larenstein University of Applied Sciences, Netherlands
|
2009 - 2010 | Cellular effects of MLK3 mutations
Co-supervisor of Ana Teresa Ferreira Correia Pinto
|
Universidade de Coimbra, Portugal
|
2007 - 2009 | MLK3, a new cancer-related gene and its associated target molecules
Co-supervisor of Filipa Sousa
|
Universidade do Porto, Portugal
|
Event organisation
Event name Type of event (Role) |
Institution / Organization | |
---|---|---|
2024/10/10 - 2025/10/11 | Together with Prof. Nuno Rodrigues dos Santos (i3S), I am organizing the SINAL conference. The SINAL meeting has served as
a catalyst for dialogue and interdisciplinary collaboration among researchers dedicated to key questions in cell biology and
signal transduction, with profound implications for the understanding and treatment of numerous human diseases. Over its various
editions, SINAL has distinguished itself as a premier forum for innovative presentations, dynamic discussions, and valuable
networking opportunities. (2025/10/10 - 2025/10/11)
Congress (Member of the Organising Committee)
|
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal |
Event participation
Activity description Type of event |
Event name Institution / Organization |
|
---|---|---|
2018 - 2018 | Technology transfer and entrepreneurship program | HiTech Program 2018 Ed.
HiSeedTech, Portugal
|
2017 - 2017 | Technology transfer and entrepreneurship program | RESOLVE program, 2nd Ed.
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
|
Jury of academic degree
Topic Role |
Candidate name (Type of degree) Institution / Organization |
|
---|---|---|
2024/11 | Estudo da sinergia de três fármacos no tratamento do carcinoma hepatocelular
(Thesis) Main arguer
|
M. F. Moreira (Master)
Universidade do Porto Faculdade de Farmácia, Portugal
|
2024/07/01 | Immunomodulatory functionalized nanoparticles to improve chemotherapeutic treatment in metastatic colorectal cancer
(Thesis) Arguer
|
Maria José Silveira (PhD)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
|
2023/06/01 | Microbiome, immune response, and cancer: A game changer triad in colorectal cancer?
(Thesis) Main arguer
|
Patrícia Vieira (PhD)
Universidade do Porto Faculdade de Medicina, Portugal
|
2023/05/01 | RBPlasticity: RNA-binding proteins’ role in normal and malignant intestinal stem cell reprogramming.
(Thesis) Main arguer
|
Rita Silva (PhD)
Universidade do Porto Faculdade de Medicina, Portugal
|
2023/03/01 | Tumor microenvironment of colorectal cancer: Podoplanin expression in neoplastic cells and cancer-associated fibroblasts and
unfavorable pathological features.
(Thesis) Main arguer
|
Ricella da Silva (Master)
Universidade do Porto Faculdade de Medicina, Portugal
|
2020 | Role of ccl18 on colorectal cancer immune modulation
(Thesis) Main arguer
|
Ana Manuela Canha Borges (Master)
Universidade do Porto Faculdade de Medicina, Portugal
|
2020 | Seeking for new p53-activating agents: effective therapies for colorectal cancer
(Thesis) Arguer
|
Helena Isabel Nogueira Ramos Rocha (PhD)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
|
2019 | Mitochondrial dynamics in thyroid cancer: unravelling the role of DRP1
(Thesis) Main arguer
|
Sara Alexandra de Sousa Barambana (Master)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
|
2019 | Identification of novel prognostic biomarkers for stage II colorectal cancer
(Thesis) Main arguer
|
Filipa Alexandra Mesquita Amorim (Other)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
|
2019 | Role of ccl18 on colorectal cancer immune modulation
(Thesis) Main arguer
|
Ana Manuela Canha Borges (Master)
Universidade do Porto Faculdade de Medicina, Portugal
|
2019 | Targeting antigen presenting cells: chitosan/poly (y-glutamic acid) nanoparticles as adjuvants to anticancer therapy
(Thesis) Arguer
|
Flávia Raquel Teixeira de Castro (PhD)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
|
2018 | Role of the RNA-binding protein MEX3A in intestinal carcinogenesis
(Thesis) Main arguer
|
Dalila de Jesus Lopes Mexieiro (Master)
Universidade do Porto Faculdade de Medicina, Portugal
|
2017/06/01 | Papel de Hakai durante la progresión tumoral: Implicaciones sobre la plasticidad epitelial
(Thesis) Arguer
|
R. C. Castosa (PhD)
Fundación Universidade da Coruña, Spain
|
2014 | Complex cell-based model of intestinal permeability
(Thesis) Main arguer
|
Joana Costa (Master)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
|
Association member
Society Organization name | Role | |
---|---|---|
2024/01/01 - Current | SPI | Member |
2024/01/01 - Current | SPO | Member |
2024 - Current | EU COST action Adaptive and acquired resistance in gastrointestinal cancers-contemporary and emerging resolutions, submitted in 2024. Invited member | Invited member |
2016/01/01 - Current | ASPIC | Member |
2009/01/01 - Current | EACR | Member |
2018 - 2019 | The Colorectal Cancer Working Group | Member of the Scientific Committee |
Committee member
Activity description Role |
Institution / Organization | |
---|---|---|
2019 - 2024 | Member of Maria José Silveira PhD's committee. “Immunomodulatory functionalized nanoparticles to improve chemotherapeutic
treatment in metastatic colorectal cancer”
Advisor / Consultant
|
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal |
Conference scientific committee
Conference name | Conference host | |
---|---|---|
2018 - 2018 | International Conference on Tumor Microenvironment, Progression, Therapy & Prevention | PT Meeting Center |
2018 - 2018 | Cancro colorretal em Portugal: da investigação à prevenção e ao tratamento | Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal |
Consulting
Activity description | Institution / Organization | |
---|---|---|
2017 - 2017 | Papel de Hakai durante la progresión tumoral: implicaciones sobre la plasticidade epitelial | Universidade da Coruña, Spain |
Course / Discipline taught
Academic session | Degree Subject (Type) | Institution / Organization | |
---|---|---|---|
2015 - Current | Module on Tumor Microenvironment | GABBA PhD Programme | Universidade do Porto Faculdade de Medicina, Portugal Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal Universidade do Porto Instituto de Biologia Molecular e Celular, Portugal Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal |
2023/09/01 - 2024/06/30 | Honorary Collaborator, Department of Anatomic Pathology, Microbiology, Preventive Medicine and Public Health and Legal Medicine and Forensics, Valladolid University (Spain), 2023-2024 and 2024-2025. BSc degree in Biomedicine and Advanced Therapies; Curricular unit: “Morpho-structural and Molecular Pathology of Human Disease”; Topic: “Molecular bases of development, clinical course, and therapeutic response of esophageal, stomach, and colon tumors”. | Molecular bases of development, clinical course, and therapeutic response of esophageal, stomach, and colon tumors (Bachelor) | Universidad de Valladolid, Spain |
Journal scientific committee
Journal title (ISSN) | Publisher | |
---|---|---|
2019 - Current | Cells (2073-4409) | MDPI |
Mentoring / Tutoring
Topic | Student name | |
---|---|---|
2019 - 2024 | Mentoring Junior Researcher (postdoctoral level) on "The role of exosomes in metastatic colorectal cancer" | Joana Carvalho |
2020 - 2020 | Visiting MSc student from the Oncology Master Program, ICBAS, UP | Diogo Coelho |
2020 - 2020 | Visiting PhD student from University of Sciences and Technology Houari Boumediene, Algeria. "Testing the effect of repurposing drugs for colorectal cancer therapy". | Allal Badredine |
2019 - 2020 | Mentoring Junior Researcher (postdoctoral level) on "Pre-clinical evaluation of novel chemical compounds for cancer treatment: tackling unmet clinical needs" | Andreia Ribeiro |
2016 - 2016 | Visiting PhD student from University of Vigo, Spain. “Metastatic functionalities of colorectal cancer cell lines are influenced by expression levels of CD26/DPP4 and partially inhibited by sitagliptin”. | Marta Quiroga |
Other jury / evaluation
Activity description | Institution / Organization | |
---|---|---|
2023 - Current | PhD grant reviewer/Evaluator for BiotechHealth PhD program | Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal |
2016 - Current | Grant Reviewer/Evaluator | Universidade de Coimbra, Portugal |
2024 - 2024 | Grant reviewer/evaluator | Fonds zur Förderung der wissenschaftlichen Forschung, Austria |
2023 - 2023 | Grant reviewer/Evaluator | World Cancer Research Fund, United Kingdom |
2023 - 2023 | Grant reviewer/evaluator | Institute Nacional du Cancer, France |
2022 - 2022 | Grant reviewer/Evaluator | Deutsche Forschungsgemeinschaft, Germany |
2015 - 2019 | Grant reviewer/evaluator | Hrvatska zaklada za znanost, Croatia |
Distinctions
Award
2024 | Patient Advocacy Award
Associação Portuguesa de Investigação em Cancro, Portugal
|
2023 | Best Oral Communication |
2022 | Patient Advocacy Award
Associação Portuguesa de Investigação em Cancro, Portugal
|
2022 | Best Oral Communication |
2021 | Assistant Researcher Contract
Fundação para a Ciência e a Tecnologia, Portugal
|
2020 | Best Oral Presentation 2020
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
|
2020 | Best Oral Communication |
2019 | ImmunoTools special Award 2019
ImmunoTools, Germany
|
2019 | Best Oral Communication |
2018 | Best Innovation Project Prize
RESOLVE program, Portugal
|
2016 | EACR prize for the best poster at the 2nd International ASPIC Meeting
European Association For Cancer Research, United Kingdom
|
2014 | Assistant Researcher Contract
Fundação para a Ciência e a Tecnologia, Portugal
|
2011 | Post-Doctoral fellowship
Fundação para a Ciência e a Tecnologia, Portugal
|
2006 | Doctoral fellowship
Fundação para a Ciência e a Tecnologia, Portugal
|